tiered royalties biopharma
Innovent and Lilly Launch Breakthrough $8.5B Global Drug Collaboration
Innovent Biologics has entered into a new strategic collaboration with Eli Lilly aimed at developing next-generation medicines for cancer and immune-related diseases, deepening a partnership that has spanned more than a decade. The agreement represents the seventh collaboration between the two companies and introduces a development model designed to accelerate Innovent’s pipeline from early discovery…
